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1. Introduction 
Alchornea cordifolia (Schum. & Thonn.) Muel. Arg. (Euphorbiaceae) is also known as Agyama in 
Ghana, Susu bolonta in Sierra Leone, Casamance bugong in Senegal, Tschiya in Togo, Bondji 
in Cameroon, Ewe ipa, Ubobo and Bambami in Nigeria. It is geographically distributed in 
secondary forest usually near water, moist or marshy places and it grows to a considerable 
height but is always of a shrubby or scrambling habit.  
The plant leaf extracts have been reportedly used in various African countries such as Senegal 
in the treatment of venereal diseases, conjunctivitis, dermatoses, stomach ulcers, bronchitis, 
cough, toothache (Le Grand and Wondergem, 1987; Le Grand, 1989). In Zaire it was used in 
the treatment of urinary tract infections, infected wounds, diarrhoea, cough, dental caries, 
chest pain and anaemia (Kambu et al., 1990; Muanza et al., 1994). In Sierra Leone it was used 
for diarrhoea and piles (Dalziel, 1956; Macfoy and Sama, 1990) and in Nigeria for gonorrhoea, 
yaws, rheumatic pain and cough (Gbile and Adeshina, 1986; Ogungbamila and Samuelson, 
1990). 
A variety of plants or materials derived from plants are been used for the prevention and 
treatment of diseases virtually in all cultures. The potential of herbal medicines and medicinal 
plant research results in health care is no longer in doubt, having gained recognition in several 
nations of the world and the World Health Organisation (WHO).  
Secondary metabolites which constitute important source of the pharmaceutical preparations 
have been reportedly isolated from different parts of plants. Some of these compounds  
have been reported to be present in A. cordifolia such as flavonoids (Ogungbamila and 
Samuelson, 1990), alkaloids and tannins (GHP, 1992), inulin and alchornine (Abdullahi et al., 
2003).  
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This work tends to investigate the phytochemical components and antibacterial activities of 
hexane extract. 
2. Materials and methods 
2.1 Collection, identification and preparation of plant leaf 
Alchornea cordifolia leaves were collected in October from Abuja, Nigeria. They were 
authenticated in the herbarium of the National Institute for Pharmaceutical Research and 
Development (NIPRD), Abuja, Nigeria where a voucher with specimen number 4334 was 
kept for future reference. The leaves were air-dried at room temperature and then reduced 
to powder using mortar and pestle.  
2.2 Preparation of the extract and its derived fractions 
Using the Soxhlet extractor, 300 gm of the powdered leaves was extracted with 450 ml of 
hexane at room temperature until all the extractable components were exhausted. The 
extract was concentrated, dried, weighed and kept in a dessicator until needed. 
Hexane extract was analysed for chemical composition using the bioassay-guided 
fractionation by employing the Accelerated Gradient Chromatography (AGC) technique. 
Silical gel G (E-Merck, Germany) was used as an absorbent. Gradient elution was effected 
using hexane and ethyl acetate sequentially with increasing polarity.  A total of 77 fractions 
were collected. The thin layer chromatography (TLC) analyses of the fractions were carried 
out using Whatman TLC plates of size 10 × 20 cm precoated with K5 silical gel 150A 
(Whatman Limited Maidstone, England). The chromatograms were developed using solvent 
mixture specific for separating alkaloid compounds especially hexane and ethyl acetate, 3:1. 
After development, the chromatograms were dried and detection was made using ultra-
violet light at both wavelength 254 nm and 365 nm. Similar fractions were pooled together 
giving 33 fractions.  
2.3 Phytochemical screening of the hexane extract 
The extract was subjected to phytochemical analysis to detect the presence of the chemical 
constituents using standard protocol (Trease and Evans 1996). 
2.4 Extraction of the secondary metabolites 
Extraction of the secondary metabolites present in the hexane extract was also carried out 
using standard methods of Marcek (1972). 
3. Antimicrobial activity 
3.1 Purification of organisms 
The organisms: Pseudomonas aeruginosa ATCC 10145, Staphylococcus aureus ATCC 12600 and 
Escherichia coli ATCC 11775 were collected from the Department of Pharmaceutical 
Microbiology, University of Benin, Benin City, Nigeria. While the clinical isolalates 
Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli and Proteus sp. were from the 
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Staff Clinic, National Institute for Pharmaceutical Research and Development, Abuja, 
Nigeria. The organisms were confirmed by sub-culturing into Nutrient broth and incubated 
at 37oC for 18 hours.    
They were further streaked on the Nutrient agar and incubated at 37oC for 18 hours.  
Biochemical tests were used to confirm the organisms. The organisms were kept on agar 
slants at 4oC until needed. 
3.2 Preparation of inoculums 
Eighteen-hour broth culture of the test organism was suspended into sterile nutrient broth. 
It was standardized according to National Committee for Clinical Laboratory Standards 
(NCCLS, 2002) by gradually adding normal saline to compare its turbidity to McFarland 
standard of 0.5 which is approximately 1.0 × 106 cfu/ml.   
3.3 Susceptibility testing 
The washed overnight broth cultures were diluted appropriately using sterile normal saline 
to 0.5 McFarland scales (0.5 McFarland is about 106 cfu/ml). The molten sterile nutrient agar 
(20 ml) was poured into sterile petri dish and allowed to set. The sterile nutrient agar plate 
was flooded with 1.0 ml of the standardized test organism and the excess was drained off 
and dried at 30oC for 1 hr.  A sterile cork borer (No. 4) was used to bore equidistant cups 
into the agar plate. One drop of the molten agar was used to seal the bottom of the bored 
hole, so that the extract will not sip beneath the agar. 0.1ml of the different concentrations 
(0.625 – 20.0 mg/ml) of the extract was added to fill the bored holes. Negative control was 
prepared by putting 0.1 ml of pure solvent in one of bored hole and aqueous solution of 2 μg 
of Gentamicin (for Gram positive bacteria) and 4 μg of Gentamicin (for Gram negative 
bacteria) (Sweetman, 2005) in another bored hole which served as positive control. One hour 
pre-diffusion time was allowed, after which the plates were incubated at 37°C for 18 h. The 
zones of inhibition were then measured in millimeter. The above method was carried out in 
triplicates and the mean of the triplicate results was taken.     
3.4 Minimum Inhibitory Concentration (M.I.C.) and Minimum Bactericidal 
Concentration (M. B. C.) 
The M.I.C. was determined by agar dilution method. Ten millilitre (10 ml) volume of double 
strength melted Mueller-Hinton agar at 45°C was diluted with equal volume of the test 
extract in graded concentrations of 0.625 – 20.0 mg/ml. These were poured aseptically into 
sterile Petri dishes and dried at 37°C for 1 h with the lid slightly raised. The solidified leaf 
extract-agar admixture plates were inoculated with 2.0 μl of standardized 18 h culture test 
organism. The inocula were allowed to diffuse into the test agar plates for 30 min. The test 
agar plates were then incubated at 37°C for 18 h. The M.I.C. value was taken as the least 
concentration of the extract showing no detectable growth.   
The M. B. C. was carried out by inoculating the concentration of the extract in the test agar 
plates showing no visible growth into sterile nutrient broth test-tubes containing 
inactivating agents 3% v/v Tween 80. These test-tubes were then incubated at 37°C for 24 h 
after which they were examined for presence or absence of growth.  
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3.5 Preliminary antimicrobial activity test of the various fractions from the hexane 
extract 
Exactly 5.0 ml of 20.0 mg/ml of the fraction was incorporated into 5.0 ml molten double 
strength sterile nutrient agar kept at 45oC and poured into sterile Petri dishes and allowed to 
set. The test organism was streaked on the poured plate and incubated at 37oC for 24 hours 
after which the activity/no activity was observed. 
4. Results 
The hexane extract (HE) of Alchornea cordifolia leaves was brown in colour. There was a yield 
of 40.22% of the extract. 
The phytochemical screening of the hexane extract of A. cordifolia leaf revealed the presence 
of tannins, alkaloids, flavonoids and phenol with tannins having the highest percentage 
yield of 6.8 (Table 1).  
 
Secondary Metabolites Yield (%) 
Tannins 6.8 
Alkaloids   5.9 
Flavonoids 4.2 
Phenol 3.2 
Table 1. Percentage yield of the secondary metabolites from the hexane extract of A. cordifolia 
leaf. 
The susceptibility of the bacteria species to the secondary metabolites of the plant showed 
that test Staphylococcus aureus was more susceptible to the secondary metabolites than the 
other bacteria species (Table 2). The zones of inhibition observed from tannins and saponin 
were larger than those from the other metabolites (Table 2). 
 
Test bacteria species Zones of inhibition (mm) 
Tannin Saponin Alkaloids Phenols 
Ps.aeruginosa 24± 0.1 20± 0.2 16± 0.0 14± 0.0 
Ps.aeruginosa ATCC 10145 21± 0.1 19± 0.1 18± 0.1 15 ± 0.1 
Staph. aureus 26± 0.3 21 ± 0.1 20± 0.0 17± 0.2 
Staph. aureus ATCC 12600 22 ± 0.1 18± 0.2 21± 0.1 16± 0.0 
E.coli 19± 0.2 16± 0.2 16± 0.0 13± 0.1 
E.coli ATCC 11775 15± 0.0 14 ± 0.2 12± 0.1 11± 0.3 
Proteus sp. 20± 0.0 22± 0.3 17 ± 0.2 12 ± 0.1 
Table 2. Susceptibility of the bacterial species to the secondary metabolites of the hexane 
extract of A. cordifolia leaf. 
The clinical isolate of Staphylococcus aureus was more susceptible to the hexane extract of the 
plant leaf than the other bacterial species (Table 3).   
The lowest Minimum Inhibitory Concentration of the hexane extract was found to be 
2.5mg/ml against Staph. aureus and Staph. aureus ATCC 12600 (Table 4).   
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Test bacteria Zones of Inhibition (mm)
20mg/ml 10mg/ml 5mg/ml 2.5mg/ml 1.25mg/ml GTM 
Ps.aeruginosa 13± 0.2 11± 0.1 NI NI NI 31 ± 0.0 
Ps.aeruginosa ATCC 10145 11± 0.0 NI NI NI NI 32 ± 0.2 
Staph. aureus 23± 0.0 19± 0.1 18± 0.2 14± 0.2 NI 23± 0.0 
Staph. aureus ATCC 12600 22± 0.2 17± 0.0 15± 0.1 12± 0.2 NI 25 ±0.1 
E.coli 11± 0.2 NI NI NI NI 20±0.2 
E.coli ATCC 11775 16± 0.1 14± 0.3 11± 0.1 NI NI 22±0.0 
Proteus sp. 15± 0.2 13± 0.0 11± 0.1 NI NI 21±0.0 
The results are expressed as mean ± standard deviation, GTM = Gentamicin, NI = No Inhibition. 
Table 3. Susceptibility of the bacterial species to different concentrations of the hexane 
extract of A. cordifolia leaf. 
 
Test Bacteria MIC (mg/ml) MBC (mg/ml) 
Ps. aeruginosa 20 NA 
Ps.aeruginosa ATCC 10145 NA NA 
Staph. aureus 2.5 5
Staph. aureus ATCC 12600 2.5 5
E .coli 20 NA 
E. coli ATCC 11775 10 20 
Proteus sp. 10 20 
Key: NA – No Activity 
Table 4. M. I. C. and M. B. C. of the hexane extract against the test bacteria species. 
 
Fractions Ps. 
aeruginosa
Ps. aeruginosa 
ATCC 10145
 Staph. 
aureus 
Staph. aureus 
ATCC 12600
E. coli E. coli ATCC 
11775
Proteus 
sp. 
HEF1-17 - - - - - - - 
HEF18 - - IN - - IN IN 
HEF19 - - IN - - IN IN 
HEF20 - - IN IN - IN IN 
HEF 21 + + + + - - - 
HEF 22 - - IN - - - - 
HEF23 - - IN - - - - 
HEF24 - - IN - - - - 
HEF25 - - IN - - - - 
HEF26 IN IN IN IN - - - 
HEF27 + + + + IN IN IN 
HEF28 + + + + + + + 
HEF29 IN IN IN IN IN IN IN 
HEF30 + + + + + + + 
HEF31 + + - - - - - 
HEF32 - - IN IN - - - 
HEF33 - - - - + + + 
KEY: - = No Activity, IN = Inhibitory or bacteristatic, + = Activity or bactericidal 
Table 5. Antibacterial activity of fractions of hexane extract of Alchornea cordifolia. 
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The hexane extract fractions (HEF) 1 – 17 showed no antibacterial activity against any of the 
bacteria species while HEF29 had bacteristatic effect and HEF 28, 30 had bactericidal effect 
against all the bacteria species (Table 5). 
5. Discussion 
The results from the phytochemical screening of the hexane extract revealed the presence of 
tannins, saponins, alkaloids and phenol. Several plants which are rich in tannins have been 
shown to possess antibacterial activities against a number of microorganisms (Doss et al., 
2009). Saponnins though are haemolytic on red blood cells, are harmless when taken orally 
and they have beneficial properties of lowering cholesterol levels in the body (Amos-Tautua 
et al., 2011). Alkaloids have been shown to possess both antibacterial (Erdemoglu et al., 2009) 
and antidiabetic (Costantino et al., 2003) activities. Phenols and phenolic compounds have 
been extensively used in disinfections and remain the standard with which other 
bactericides are compared (Uwumarongie et al., 2007). 
The antibacterial activities exhibited by the secondary metabolites: tannins, saponins, 
alkaloids, and phenols extracted from the hexane extract of A. cordifolia leaf can be responsible 
for the antibacterial activity of the extract. The presence of secondary metabolites in plants 
have been reported to be responsible for their antibacterial properties (Rojas et al., 2006; 
Nikitina et al., 2007; Udobi et al., 2008; Rafael et al., 2009; Adeshina et al., 2010). The broad 
spectrum of antibacterial activity showed by the hexane extract against Gram positive and 
Gram negative bacteria can be attributed to the presence of the secondary metabolites. All the 
secondary metabolites showed more antibacterial activity against the gram-positive bacteria 
than the gram-negative bacteria. This is similar to the results of Adeshina (2005) who 
discovered that tannins, saponin, alkaloid and phenol from the leaf methanol, water and ethyl 
acetate extracts of Alchornea cordifolia had antibacterial activities against gram-positive bacterial 
strains more than gram-negative bacteria. Banso and Adeyemo (2007) also detected that 
tannins and alkaloids from Dichrostachys cinerea possessed antibacterial activities against gram-
positive bacterial strains more than gram-negative bacteria.   
The hexane extract appeared to be more active against the gram positive bacteria, Staph. 
aureus, than the Gram negative bacteria species. Gram negative bacteria are known to be 
resistant to the action of most antibacterial agents including plant based extracts and these 
have been reported by many workers (Kambezi and Afolayan, 2008; El-Mahmood, 2009). 
Gram negative bacteria have an outer phospholipids membrane with the structural 
lipopolysaccharide components, which make their cell wall impermeable to antimicrobial 
agents. 
The bactericidal action of HEF28 and HEF30 against all the tested bacteria species can be an 
indication that these fractions possess the active ingredients responsible for antibacterial 
activity of the hexane extract of Alchornea cordifolia leaf. HEF21 and HEF27 displayed notable 
antibacterial activities against Staph. aureus and Pseudomonas aeruginosa that is of great 
importance because the infections cause by these bacteria are known to be difficult to 
control. Staphylococcus aureus has been reported by many workers to have developed 
resistance to most antibiotics and Pseudomonas aeruginosa is an opportunistic organism 
which has been reported to readily receive resistance carrying plasmid from other bacteria 
species (Wiley et al., 2008). HEF33 also showed noteworthy bactericidal action against the 
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tested enteric bacteria-E. coli and Proteus sp. Enteric bacteria are known to transmit 
resistance plasmid among themselves (Brooks et al., 2008) therefore developing resistance to 
many antibiotics. In view of all these observations, these fractions: HEF28, HEF30, HEF21, 
HEF27 and HEF33 can further be worked on to get their structures and other necessary 
properties needed for formulation into newer antibiotics.  
In conclusion, the hexane extract and fractions of Alchornea cordifolia leaf possess broad 
spectrum of antibacterial activity against the test bacteria species. Five out of the thirty-three 
fractions displayed potential antibacterial activity that can be explored as remedy for human 
bacterial infections. The results obtained from this work gives high hope for the 
development of new antibacterial agents. 
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